Perno C F, Baseler M W, Broder S, Yarchoan R
Clinical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
J Exp Med. 1990 Apr 1;171(4):1043-56. doi: 10.1084/jem.171.4.1043.
Infection of monocyte/macrophages (M/M) by a variety of viruses (including HIV-1) has been shown to be enhanced in the presence of low concentrations of antiviral antibodies. This process has been hypothesized as occurring through binding of the virus-antibody complex to Fc or complement receptors followed by endocytosis. In the current study, we explored whether such a mechanism might provide a CD4-independent route of infection by HIV-1 for any of several populations of M/M. In the absence of anti-HIV antibodies, replication of HIV-1 in M/M was blocked by viral binding inhibitors such as soluble CD4 or OKT4A mAb. Furthermore, while infection of the M/M populations by a low multiplicity of infection of HIV-1 was found to be somewhat enhanced by the presence of very low concentrations of anti-HIV antibodies, this process was also consistently inhibited by recombinant soluble CD4 and by OKT4A antibody. These results suggest that under the variety of conditions studied, CD4 binding was an essential step in the infection of M/M by HIV. Moreover, they are consistent with the notion that "enhancing" antibodies may serve to concentrate HIV onto CD4 receptors or, alternately, may act at other steps in the process of viral entry and replication.
多种病毒(包括HIV-1)对单核细胞/巨噬细胞(M/M)的感染在低浓度抗病毒抗体存在时会增强。这一过程被推测是通过病毒-抗体复合物与Fc或补体受体结合,随后发生内吞作用而发生的。在本研究中,我们探讨了这种机制是否可能为HIV-1提供一条不依赖CD4的感染几种M/M细胞群体的途径。在没有抗HIV抗体的情况下,HIV-1在M/M细胞中的复制被病毒结合抑制剂如可溶性CD4或OKT4A单克隆抗体阻断。此外,虽然发现极低浓度的抗HIV抗体的存在会使HIV-1以低感染复数对M/M细胞群体的感染有所增强,但这一过程也始终受到重组可溶性CD4和OKT4A抗体的抑制。这些结果表明,在所研究的各种条件下,CD4结合是HIV感染M/M细胞的一个必要步骤。此外,它们与“增强”抗体可能将HIV集中到CD4受体上,或者可能在病毒进入和复制过程的其他步骤起作用的观点一致。